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Summary
We report a novel X-linked mental retardation (XLMR)
syndrome, with characteristic facial dysmorphic fea-
tures, segregating in a large North Carolina family. Only
males are affected, over four generations. Clinical find-
ings in the seven living affected males include amoderate
degree of mental retardation (MR), coarse facies, puffy
eyelids, narrow palpebral fissures, prominent supraor-
bital ridges, a bulbous nose, a prominent lower lip, large
ears, obesity, and large testicles. Cephalometric mea-
surements suggest that the affected males have a dis-
tinctive craniofacial skeletal structure, when compared
with normative measures. Obligate-carrier females are
unaffected with MR, but the results of cephalometric
skeletal analysis suggest craniofacial dysmorphisms in-
termediate between affected males and normative con-
trol individuals. Unaffected male relatives show no clin-
ical or cephalometric resemblance to affected males. The
blood-lymphocyte karyotype and the results of DNA
analysis for fragile-X syndrome and of other routine
investigations are normal. Linkage analysis for poly-
morphic DNA markers spanning the X chromosome es-
tablished linkage to Xq26-q27. Maximum LOD scores
were obtained at marker DXS1047 (maximum LOD
score = 3.1 at recombination fraction 0). By use of
haplotype analysis, we have localized the gene for this
condition to an 18-cM genetic interval flanked by
ATA59C05 and GATA31E08. On the basis of both the
clinical phenotype and the mapping data, we were able
to exclude other reported XLMR conditions. Therefore,
we believe that a unique recessive XLMR syndromewith
a distinctive and recognizable phenotype is represented
in this family.
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Introduction
X-linked mental retardation (XLMR) conditions are
common, representing an estimated range of 10%–50%
of all cases of mental retardation (MR) (Turner et al.
1970; Lehrke 1972; Turner 1982; Opitz et al. 1986; Kerr
et al. 1991). These are genetically heterogeneous, and,
for most types, the underlying genetic basis has not yet
been identified (Gedeon et al. 1994). At present, the
nosology of XLMR can be broadly grouped into two
categories: (1) XLMR syndromes that are associated
with a specific or characteristic phenotype and (2) those
cases of XLMR that do not present with consistent clin-
ical features (Kerr et al. 1991). The latter are more fre-
quent than are the syndromic XLMR conditions.
Characterization of the specific clinical features as-
sociated with a syndromic form of XLMR permits iden-
tification of individuals in sufficient numbers to enable
more-accurate genetic counseling and, ultimately, gene
identification (Lubs et al. 1996a). Identification of the
underlying genetic basis is necessary to improve nosol-
ogy, to understand the disease pathogenesis, and to per-
mit development of better diagnostic and management
strategies.
Here we report the clinical description and localiza-
tion of a gene locus for a novel X-linked MR syndrome.
The family was ascertained by identification of seven
mentally retarded males from a North Carolina family.
The results of examination of the pedigree were consis-
tent with an X-linked recessive mode of inheritance.
Clinical examination of normal males and males with
MR revealed several phenotypic features that appeared
to be present only in males with MR. Cephalometric
radiographic analysis revealed a unique craniofacial
skeletal profile in affected males. Although several of
these clinical findings are present in other XLMR con-
ditions, the composite phenotype appears to be unique
and has previously been unreported. To evaluate sup-
port for linkage to the X chromosome and to localize
the responsible gene, genetic-linkage analysis was per-
formed. These analyses localized the gene locus for this
condition to an 18-cM region on chromosome Xq26-
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Figure 1 Pedigree of the family, showing an X-linked recessive mode of inheritance and the haplotypes of the members studied.
The consultand is indicated by the arrow. Genetic-map distances are derived from the female chromosome X genetic map.
q27. Although a number of XLMR conditions have been
mapped to this region, none appears to be consistent
with our findings in this family. Thus, on the basis of
both the unique clinical phenotype and the results of our
mapping studies, we believe that this represents a hith-
erto undescribed syndromic form of XLMR.
Case Reports
A 33-year-old woman (individual IV-11; fig. 1) re-
quested genetic consultation for her four mentally re-
tarded brothers after reading an article on fragile-X syn-
drome. She was also interested in knowing her own risk
of having an affected child. A detailed family history
was taken. The results of pedigree analysis were consis-
tent with X-linked recessive inheritance. Seven living af-
fected males were identified; all received a complete
physical examination. One affected male (individual IV-
9; figs. 1 and 2) died in his 40s, after a flulike illness.
His photographs show a marked resemblance to the
other affected males.
All seven living affected males share a distinctive facial
appearance (fig. 2) that consists of coarse facies, prom-
inent supraorbital ridges, periorbital fullness, narrow
Figure 2 Composite picture of affected males, showing characteristic facial features. In order, these males are individuals III-2
(A), IV-3 (B), IV-4 (C), IV-5 (D), IV-6 (E), IV-9 (F), V-3 (G), and V-4 (H). Individual IV-9 is deceased. Individual III-2 has recently lost
1100 lbs., as a result of dietary restrictions required because of diabetes mellitus.
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Figure 3 Photo of unaffected male (individual IV-10), illus-
trating lack of resemblance to the affected males.
Table 1
Clinical Features of Affected Males
INDIVIDUAL
FEATURE III-2 IV-3 IV-4 IV-5 IV-6 V-3 V-4
Age (years) 71 50 46 44 39 35 21
BMIa 42 38 40 31 40 46 34
Height (percentile) !3d 10th–25th 3d !3d 10th 90th 50th
OFCb (percentile) 10th 50th 25th 3d 25th 25th 3d
Coarse facies       
Puffy eyelids       
Narrow PFsc       
Prominent supraorbital ridge       
Bulbous nose       
Prominent lower lip       
Large ears       
Large testes     d  
a BMI 130 is indicative of obesity.
b OFC = occipitofrontal circumference.
c PFs = palpebral fissures.
d Right testis undescended.
palpebral fissures, a bulbous nose, a prominent lower
lip, and large ears. They are all obese and have large
testes. Determination of obesity was based on calcula-
tion of body-mass index (BMI), where BMI = wt (kg)/
ht (m2); a BMI 130 was considered to be indicative of
obesity (Cole 1991). All affected males have normal sec-
ondary sexual characteristics. Testicular volumes were
either measured by use of an orchidometer or based on
length and width measurements by use of a standard
formula (Nielson et al. 1982). Volumes 134 ml were
considered to be indicative of macroorchidism. Clinical
features of the affected males are summarized in table
1. In addition, individuals IV-4 and IV-6 had cataracts
develop during the 4th decade. Individual III-2 had cat-
aracts diagnosed at age 55 years. There is no history of
seizures or of progressive neurological deterioration.
Formal psychological testing was performed on in-
dividuals IV-3 and IV-5; their IQs are assumed to be
representative of those of the other affected males, since
all are similarly affected. The full-scale IQs were 55 and
52, respectively, on the Wechsler Adult Intelligence Scale.
On the Vineland Adaptive Behavior Scales, the com-
posite scores were 27 and 28, respectively, with both
scores being close to the age equivalent of 4 years 9 mo.
Thus, on the basis of the IQ and adaptive (self-help)
scores, both individuals are regarded as being moder-
ately mentally retarded. Individual IV-3 holds a job as
a sweeper, but none of the others are able to work. They
can care for themselves and can do chores at home.
Unaffected males in the family (see figs. 1 and 3) share
no resemblance to their affected male relatives. All three
living unaffected males who are at risk (individuals IV-
1, IV-7, and IV-10; fig. 1) have received a high-school
education and hold jobs. Obligate-carrier females have
no abnormal physical findings. Individual III-1, who is
an obligate carrier, is reported to have had learning dif-
ficulties in school but has been able to cope well with
daily-living skills and has raised a large family.
A blood-lymphocyte karyotype and DNA testing for
fragile-X syndrome were performed on individual IV-3;
the results of both tests were normal. A separate cyto-
genetic study was performed to look for a fragile X,
because of the possibility of fragile X syndrome E–MR;
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the findings were normal. Complete skeletal radio-
graphs, performed on individual IV-3, did not show any
abnormalities. A blood smear for hemoglobin H stain-
ing, done on individual IV-4, did not show any inclu-
sions. Thyroid-function tests, which were performed on
individual IV-3 because of the individual’s coarse facial
features, were normal. No abnormalities were evident
on magnetic-resonance imaging of the head of individual
IV-3.
Cephalometric Analyses
Standard lateral cephalography was performed on
individuals IV-3, IV-5, IV-10, and III-1, with use of a
B. F. Wehmer cephalostat. The radiographs were digi-
tized and analyzed, by use of the Quick Ceph II com-
puter program (1986–91, Dr. Gunther Blaseio), and
subjected to Steiner analysis (Steiner 1953; Riolo 1974).
The affected males showed lip protrusion and a vertical
mandibular angle, despite being edentulous. In contrast,
the normal male (individual IV-10) showed no lip pro-
trusion and had a horizontal or flat mandibular-plane
angle. The results of the same analysis, done on the
carrier female (individual III-1), showed the typical pat-
tern seen in an edentulous individual, with collapse of
the lips into the face. The angle of the mandible was
intermediate, lying between the measurements for the
affected males and that for the unaffected male (figure
4). The anterior cranial base in the affected males and
the carrier female was 10% shorter than in the normal
male.
DNA and Linkage Analyses
Fifteen family members consented to provide speci-
mens for DNA analysis (fig. 1). Peripheral blood was
collected into acid citrate–buffered Vacutainer tubes
and, by means of the CytoSoft brush kit (CP-50; Medical
Packaging Company), onto buccal swabs. Genomic
DNA was extracted from peripheral blood, by use of
the QIAmp blood kit (Qiagen). DNA was extracted from
the buccal swab by use of 600 ml 50 nM NaOH; this
was followed by vortexing and by 5 min in a 95C water
bath. The swab was discarded, and 60 ml Tris, 1 M: pH
8.0 was added. The solution was decanted and was
stored at 70C until use.
Linkage analysis of chromosome X was performed
with the use of Weber, version 8A, high-density markers
(Research Genetics) (table 2), by use of standard tech-
niques for PCR amplification, with g[32P] radioactively
labeled oligonucleotide primers, as described elsewhere
(Weissenbach et al. 1992). After identification of a link-
age relationship to DXS1001–DXS1227, a high-density
array of 10 short-tandem-repeat polymorphism (STRP)
markers, selected from The Cooperative Human Linkage
Center chromosome X integrated marker map, version
v8c7, was evaluated for linkage, to refine the candidate
interval. After PCR amplification, individual samples
were separated on a 6% PAGE 7-M urea gel (30/1,500
[w/v]). An M13 sequencing ladder (Sequenase kit; USB)
was loaded onto each gel, to permit sizing of individual
alleles. After electrophoresis, gels were wrapped in cel-
lophane, were exposed in a phosphorimaging cassette,
and were scanned (Molecular Dynamics). Alleles were
scored, and genotype data were entered into the pedigree
file of the LINKAGE computer package (Lathrop et al.
1984).
LOD scores were generated, with the assumption of
X-linked recessive inheritance with complete penetrance
in males. Carrier females were assumed to be clinically
unaffected. The affected-allele frequency was .0001.
Marker-allele frequencies were assumed to be distributed
uniformly. Two-point linkage analysis was performed by
use of MLINK, version 5.1, from the LINKAGE com-
puter program (Lathrop et al. 1984). Haplotype analysis
was used both for error elimination during linkage scan
and for the determination of the critical linkage segment.
Haplotype construction was performed by means of the
CRIMAP program with the CHROMPIC option (Lan-
der and Green 1987).
Results
Two-point linkage analysis of the entire X chromo-
some either failed to support or rejected the linkage hy-
pothesis for all STRP loci tested, except for those in the
interval flanked by GATA172DO5F and GATA31E08,
a genetic interval of 38 cM (table 2). The seven affected
males all have alleles for these STRP markers—a finding
that makes it unlikely that a submicroscopic deletion
could be responsible for the phenotype. Linkage analysis
of a high-density panel of STRP loci spanning this in-
terval permitted us to refine the candidate interval to
∼18 cM, flanked by ATA59C05 and GATA31E08 (fig.
1). This genetic interval contains loci for 10 X-linked
MR conditions, and it also contains a number of po-
tential candidate genes for XLMR (Yntema et al. 1998).
Discussion
XLMR conditions are subdivided into two cate-
gories: syndromic and nonspecific (Kerr et al. 1991;
Gedeon et al. 1994). In syndromic XLMR, affected
males exhibit characteristic phenotypic or neurolog-
ical manifestations that result in a unique and rec-
ognizable condition. In contrast, in nonspecific
XLMR, there is no consistent phenotypic manifesta-
tion other than MR. Advances in mapping of both
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Figure 4 Composite picture of cephalometric measurements in affected males IV-3 and IV-5 (A and B, respectively), showing
vertical mandibular angle, in comparison with that in unaffected male IV-10 (D). The mandibular angle in carrier female III-1 (C) is
between that of the affected males and that of the unaffected male. Note the lip protrusion in the affected males.
syndromic and nonspecific forms of XLMR (Lubs et
al. 1996a, 1996b) have helped to increase our un-
derstanding of XLMR. Although most syndromic
forms of XLMR are rare (Gedeon et al. 1994), clinical
reports and mapping studies enable clinicians to rec-
ognize and to accurately counsel other families. We
report a hitherto undescribed form of recessive XLMR
with a distinctive phenotype that conforms to a rec-
ognizable syndrome.
The salient clinical features in the affected males (fig.
2) are MR, coarse facies, puffy eyelids with narrow pal-
pebral fissures, prominent supraorbital ridges, a prom-
inent lower lip, large ears, and large testes. As is shown
in figure 3, these features are not seen in unaffected male
relatives. Although all the affected males are obese, it is
possible that the obesity could be either exogenous or a
family trait unrelated to the MR, since several other
members of the family are obese, including carrier fe-
males and an unaffected male (individual IV-10). Onset
of obesity in the affected males has been variable, with
a range from early childhood to the 3d decade. Since
macroorchidism can be an inherited trait independent
of MR, we tried to obtain testicular measurements of
the unaffected males; however, we were unsuccessful be-
cause of reasons of embarrassment and modesty. How-
ever, none of the unaffected males stated that they have
Shashi et al.: Unique XLMR Syndrome 475
Table 2
Summary of High-Density Chromosome X Screening Markers
Marker
Distance from
Xp Telomere
(cM)
Meiotic
Recombination
Recombinant
Individual(s)a
DXS9900 0 Detected IV-3–IV-5, IV-7
DXS9895 9 Detected IV-2, IV-4, IV-5, IV-7
DXS9902 22 Uninformative
DXS9896 40 Detected IV-2, IV-4, IV-5
DSX6810 64 Uninformative
GATA144D04F 71 Detected IV-2, IV-5
DXS7132 83 Detected IV-2, IV-5
DXS6800 93 Detected IV-2, IV-5
DXS6789 104 Uninformative
DXS6797 113 Detected IV-4
GATA172DO5F 116 Detected IV-4
GATA165B12F 133 Uninformative
DXS1047 143 Not Detected None
GATA31E08 154 Detected IV-3, IV-5
DXS1227 159 Detected IV-3, IV-5
DXS7127 165 Detected IV-3, IV-5
DXYS154 184 Uninformative
a Individuals of generation V were not tested with the screening markers.
large testicles. Early onset of cataracts (i.e., during the
4th decade) was seen in individuals IV-4 and IV-6 but
was not seen in the other affected males, which makes
it difficult to definitively link this to the MR. Obligate-
carrier females show no phenotypic abnormalities, but
learning difficulties reportedly have been experienced by
some of them. The results of such investigations as
blood-lymphocyte karyotyping, DNA analysis for frag-
ile-X syndrome, skeletal radiography, and magnetic-res-
onance imaging of the head were normal. The results of
cephalometric analysis of affected males, an unaffected
male, and an obligate-carrier female showed a distinctive
craniofacial profile in the affected males. The carrier fe-
male had mild abnormalities.
We generated two lists of differential diagnoses; one
was based on the clinical characteristics, and the other
was based on the results of the linkage studies. Given
the clinical features identified in the affected males,
several well-known XLMR syndromes were consid-
ered in the differential diagnosis (table 3). Coffin-
Lowry syndrome (CLS) (Coffin et al. 1966; Lowry et
al. 1971; Young 1988) is characterized by MR, a
coarse facial appearance, hypertelorism, a bulbous
nose, and protuberant lips. Although our patients
have some of these features, their facial appearance
is distinctive, and they do not have the characteristic
tapering of the fingers or skeletal abnormalities (the
tufted-drumstick appearance of the distal phalanges)
seen in CLS. CLS has been mapped to chromosome
Xp22 (Hanauer et al. 1988), with mutations within
the ribosomal protein S6 kinase 2 gene (RSK2) being
causative (Trivier et al. 1996). Our studies established
linkage to Xq26-q27—a finding that suggests that this
syndrome is not CLS. Our patients do have some fea-
tures—such as MR, coarse facies, prominent supra-
orbital ridges, large ears, and obesity—that are seen
in Bo¨rjeson-Forssman-Lehmann syndrome (BFLS
[MIM 301900]); however, they do not have micro-
cephaly, hypogonadism with gynecomastia, and/or
poor sexual development, which are seen in all males
with BFLS (Bo¨rjeson et al. 1962; Weber et al. 1978;
Robinson et al. 1983; Dereymaeker et al. 1986;
Turner et al. 1989). Seizures, reported in 50% of
individuals with BFLS, are not a feature in our pa-
tients. In addition, other common features, such as
short stature, nystagmus, and radiographic changes
(e.g., steep radiocarpal angle and small femoral and
humeral heads) (Robinson et al. 1983), are absent in
our patients. Although the gene for BFLS has not yet
been identified (Gedeon et al. 1996), it has been
mapped to Xq26-q27 (fig. 5) (Mathews et al. 1989;
Turner et al. 1989). The candidate gene SOX3, an
SRY-like gene in this region, was found to have no
mutations in patients with BFLS (Gedeon et al. 1996).
The candidate interval for BFLS overlaps with our
area of linkage, but the differences in clinical features
suggest that these are distinctive conditions. Males
with Simpson-Golabi-Behmel syndrome (SGBS [MIM
312879]) have MR, overgrowth (adult height 197th
percentile), macrocephaly, upward-slanting palpebral
fissures, an upturned nose, a prominent chin, large
dysplastic kidneys, postaxial polydactyly of the hands,
cardiac conduction defects, and typical radiological
manifestations (e.g., flared iliac wings and narrow sac-
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Table 3
Clinical Manifestations of Some Well-Known X-Linked MR Syndromes, Compared with Those Seen in the Present Study
FINDINGS IN THE PRESENT STUDY AND CHARACTERISTICS OF X-LINKED MR SYNDROMES
CLINICAL
MANIFESTATION
Present
Report BFLS Coffin-Lowry Simpson-Golabi Atkin Baraitser
MR Moderate Severe Severe Variable Moderate-severe Moderate
Head size Normal Microcephalic Microcephalic/normal Macrocephalic Macrocephalic Macrocephalic
Hypertelorism Absent Absent Present Present Present Absent
Diastema Absent Absent Absent Absent Present Present
Narrow eyes Present Absent Absent Absent Absent Absent
Supraorbital ridges Prominent Prominent Prominent Not prominent Prominent Prominent
Thick lower lip Present Absent Present Variable Present Present
Large ears Present Present Absent Absent Present Present
Obesity Present Present Absent Absent Present Present
Heart defect Absent Absent Present Present Absent Absent
Testes Large Undescended/small Undescended/small Undescended/small Large Large
Stature Normal Short Short Normal to tall Short Normal
Skeletal radiographs Normal Abnormal Abnormal Abnormal Normal Not available
Mapping Xq26 Xq26-q27 Xp22.1-p22.2 Xq26 Unknown Unknown
roiliac notches) (Simpson et al. 1975; Golabi and Ro-
sen 1984: Behmel et al. 1988; Hughes Benzie et al.
1992; Chen et al. 1993; Terespolsky et. al. 1995).
None of these features are seen in our patients. In
addition, our patients have features not seen in SGBS
(table 3). Mutations within the glypican 3 (GPC3)
gene, which is localized to Xq26, are responsible for
SGBS (Pilia et al. 1996). Although GPC3 is contained
within our candidate region, the phenotypic differ-
ences suggest that our patients have another distinct
condition. X-linked alpha-thalassemia MR syndrome
(ATR-X [MIM 300032]) (Gibbons et al. 1991, 1995)
is unlikely in this family, since none of the affected
males are anemic and since the results of HbH staining
in individual IV-4 were normal. In addition, ATR-X
is caused by mutations in the X-linked helicase-2
(XH2) gene localized to Xq13, whereas our studies
show linkage to Xq26-q27. An XLMR syndrome de-
scribed elsewhere (Atkin et al. 1985) was included in
the differential diagnosis. Our patients could be dis-
tinguished from those in the study by Atkin et al., on
the basis of absence of macrocephaly, hypertelorism,
short stature, broad and short hands, diastema, and
microdontia, all of which are features seen in Atkin
et al.’s report (table 3). Clark and Baraitser (1987)
described XLMR with macrocephaly, obesity, and ma-
croorchidism, and, thereafter, additional cases were
reported elsewhere (Baraitser et al. 1995; de Pina-
Neto and de Molfetta 1998). The clinical features of
this condition, which are listed in table 3, are quite
distinct from those of the patients in the present study,
although there are some similarities. Ultimately, the
nosology of XLMR will be established when the in-
dividual causative genes are identified; however, after
careful comparison of the clinical features in this fam-
ily with those of the XLMR conditions described
above, we are confident that our patients do not con-
form to other well-known syndromic forms of X-
linked MR.
The mapping studies in this family support linkage to
an 18-cM genetic interval, flanked by ATA59C05 and
GATA31E08 (maximum LOD score = 3.1 at , atv = 0
DXS1047), on Xq26-q27. This interval is 20 Mb. On
the basis of this genetic localization, we considered other
XLMR syndromes in close proximity (fig. 5). Gustavson
syndrome is characterized by microcephaly, severe MR,
optic atrophy with visual impairment, hearing loss, spas-
ticity, seizures, and restricted joint mobility (Gustavson
et al. 1993; Malgrem et al. 1993). These features are
clearly different from those seen in the family that we
studied. Hereditary motor-sensory neuropathy, deafness,
and MR occur in Cowchock syndrome (Cowchock et
al. 1985), which has been mapped between DXS425 and
HPRT. In addition to having features not seen in Cow-
chock syndrome, our patients do not have neuropathy
and deafness, which are seen in Cowchock syndrome.
Lesch-Nyhan syndrome, a disorder of purine metabo-
lism (MIM 308000), is caused by mutations in the hy-
poxanthine phosphoribosyltransferase (HPRT) gene on
chromosome Xq26 (Bland JH 1968; Davidson et al.
1991; Huang et al. 1991). The clinical manifestations
(except for MR)—consisting of choreoathetosis with on-
set in infancy, loss of milestones, self-injurious behavior
later in childhood, MR, and gouty symptoms—are un-
doubtedly different from those found in the present
study. A few nonspecific X-linked MR conditions have
been mapped to this interval, as can be seen in figure 5
(Yntema et al. 1998). The family that we studied has,
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Figure 5 Schematic localization of a unique XLMR syndrome, as implied by the current report, in relation to other reported
XLMR conditions in close proximity. Vertical arrows indicate DNA markers tested in the present study. Asterisks (*) indicate markers
that have previously been linked to other XLMR conditions. Mutations within the GPC3 gene have been found in SBGS. CS = Cowchock
syndrome, GS = Gustavson syndrome, SG = SGBS , XPH = X-linked recessive panhypopituitarism, MR-IGHD = mental retardation with
isolated growth hormone deficiency, and MRX = nonspecific XLMR.
along with MR, a unique phenotype that distinguishes
this entity from nonspecific XLMR.
In conclusion, we have described a new form of syn-
dromic XLMR that maps to chromosome Xq26-q27. As
part of the differential diagnoses, we have considered
conditions with a similar phenotype and, also, those
XLMR conditions that have been mapped in close prox-
imity. We did not find the features in this family to be
consistent with those seen in any of the previously de-
lineated forms of XLMR syndromes. Although reports
such as this one describe a single family, they permit
clinicians to recognize similar families. This could lead
to better understanding of the condition and could also
enable identification of the gene, permit understanding
of the pathogenesis, help in molecular diagnostics, and
enable clinicians to provide more-accurate genetic coun-
seling for families.
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